United States· US:80830-1691_a90bfcad-c5c8-4429-bd89-25d1a3989054
POTASSIUM PHOSPHATES
A medicinal product containing potassium phosphate, monobasic; potassium phosphate, dibasic, registered in United States by Amneal Pharmaceuticals Private Limited.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- POTASSIUM PHOSPHATE, MONOBASIC; POTASSIUM PHOSPHATE, DIBASIC
- Manufacturer
- Amneal Pharmaceuticals Private Limited
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 1
- ndc1180830-1691-7
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Potassium phosphate, monobasic; potassium phosphate, dibasic in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaPOTASSIUM PHOSPHATESSANDOZ CANADA INCORPORATED
- GermanyKaliumphosphat B. BraunB.Braun Melsungen Ag
- IrelandPotassium Phosphate 1mmol/ml + 0.6mmol/ml Concentrate for Solution for InfusionB. Braun Medical Limited
- NorwayPotassio fosfato galenica seneseIndustria Farmaceutica Galenica Senese
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Belgium · Kaliphos, Kaliumfosfaat B. Braun
- Germany · Kaliumphosphat B. Braun
- Ireland · Potassium Phosphate B Braun Medical
- Italy · Potassio Fosfato Bioindustria L.I.M., Potassio Fosfato Galenica Senese
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b309c5fd-f59c-4979-a63f-89d0b51725cf GET /v1/drugs/b309c5fd-f59c-4979-a63f-89d0b51725cf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "224; 236",
"substance": "POTASSIUM PHOSPHATE, MONOBASIC; POTASSIUM PHOSPHATE, DIBASIC",
"productndc": "80830-1691",
"dosage_form": "SOLUTION, CONCENTRATE",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL",
"application_number": "ANDA216344",
"marketing_category": "ANDA"
}See everything about potassium phosphate, monobasic; potassium phosphate, dibasic.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.